Hilmar Schiller

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Cystic Fibrosis

Machine Learning

Drug Administration

Heat Shock Protein

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Carolina Säll, Upendra Argikar, Kari Fonseca, Constanze Hilgendorf, Filipe Lopes, Jens Riedel, Hilmar Schiller, Anders Sonesson, Kenichi Umehara, Kai Wang
Industry Perspective on Therapeutic Peptide Drug-Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper. Clinical pharmacology and therapeutics (2023)
Carolina Säll, Upendra Argikar, Kari Fonseca, Constanze Hilgendorf, Filipe Lopes, Jens Riedel, Hilmar Schiller, Anders Sonesson, Kenichi Umehara, Kai Wang
Industry perspective on therapeutic peptide drug-drug interaction assessments during drug development: a European Federation of Pharmaceutical Industries and Associations white paper. Clinical pharmacology and therapeutics (2023)
David E Coutant, David Boulton, Upendra P Dahal, Antoine Deslandes, Christine Grimaldi, Joao Ns Pereira, Carolina Säll, Hetal Sarvaiya, Hilmar Schiller, Guoying Tai, Kenichi Umehara, Yang Yuan, Shannon Dallas
Therapeutic Protein Drug Interactions: A White Paper from the International Consortium for Innovation and Quality in Pharmaceutical Development. Clinical pharmacology and therapeutics (2022)